PPA
CVAC

Parametric Portfolio Associates’s CureVac CVAC Stock Holding History

Parametric Portfolio Associates’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$3.4M Buy
173,240
+108,852
+169% +$2.17M ﹤0.01% 2105
2021
Q4 		$2.21M Buy
64,388
+48,384
+302% +$1.95M ﹤0.01% 2378
2021
Q3 		$874K Buy
16,004
+6,352
+66% +$383K ﹤0.01% 2857
2021
Q2 		$709K Buy
9,652
+6,739
+231% +$674K ﹤0.01% 2929
2021
Q1 		$266K Buy
+2,913
New +$283K ﹤0.01% 3764

Other funds holding CVAC

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Parametric Portfolio Associates's CVAC Position: Q1 2022 in Review

Parametric Portfolio Associates increased its CureVac (CVAC) stake by 169% in Q1 2022, buying an estimated $2.17M and bringing the position to 173,240 shares worth $3.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2105.

Parametric Portfolio Associates first reported a position in CVAC in Q1 2021 and has held it in 5 quarters since. 111 funds tracked by Wall St. Rank hold CVAC as of Q1 2022.

  • Parametric Portfolio Associates held 173,240 shares of CureVac worth $3.4M as of Q1 2022.
  • Parametric Portfolio Associates bought 108,852 CureVac shares in Q1 2022, an estimated $2.17M.
  • CureVac made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2105 holding.
  • Parametric Portfolio Associates first reported a position in CureVac in Q1 2021 and has held it in 5 quarters since.
  • 111 funds tracked by Wall St. Rank held CureVac as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.